Jove
Visualize
Contact Us
JoVE
x logofacebook logolinkedin logoyoutube logo
ABOUT JoVE
OverviewLeadershipBlogJoVE Help Center
AUTHORS
Publishing ProcessEditorial BoardScope & PoliciesPeer ReviewFAQSubmit
LIBRARIANS
TestimonialsSubscriptionsAccessResourcesLibrary Advisory BoardFAQ
RESEARCH
JoVE JournalMethods CollectionsJoVE Encyclopedia of ExperimentsArchive
EDUCATION
JoVE CoreJoVE BusinessJoVE Science EducationJoVE Lab ManualFaculty Resource CenterFaculty Site
Terms & Conditions of Use
Privacy Policy
Policies

Filters

Cancer letters

Showing results (241-250 of 17,056) with videos related to

Pageof 1,706
Sort By:
Cancer Letters|August 12, 2017
PD-1/PD-L1 blockade enhances the efficacy of SA-GM-CSF surface-modified tumor vaccine in prostate cancerXiaojun Shi, Xinji Zhang, Jinlong Li, et al.
Cancer Letters|August 12, 2017
The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancerKang-Seo Park, Hannah Yang, Junyoung Choi, et al.
Cancer Letters|August 5, 2017
Drug combination approach to overcome resistance to EGFR tyrosine kinase inhibitors in lung cancerChristy W S Tong, William K K Wu, Herbert H F Loong, et al.
Cancer Letters|August 6, 2017
EGFR/c-myc axis regulates TGFβ/Hippo/Notch pathway via epigenetic silencing miR-524 in gliomasKai Zhao, Qixue Wang, Yunfei Wang, et al.
Cancer Letters|September 27, 2017
Speeding towards individualized treatment for pancreatic cancer by taking an alternative roadJuan Iovanna, Nelson Dusetti
Cancer Letters|September 20, 2017
Up-regulation of Rho-associated kinase 1/2 by glucocorticoids promotes migration, invasion and metastasis of melanomaGao-Xiang Huang, Yan Wang, Jie Su, et al.
Cancer Letters|September 28, 2017
NEMO peptide inhibits the growth of pancreatic ductal adenocarcinoma by blocking NF-κB activationZhuonan Zhuang, Hao Li, Harold Lee, et al.
Cancer Letters|September 28, 2017
Targeting COPZ1 non-oncogene addiction counteracts the viability of thyroid tumor cellsMaria Chiara Anania, Elena Cetti, Daniele Lecis, et al.
Cancer Letters|September 4, 2017
Palbociclib, a selective CDK4/6 inhibitor, enhances the effect of selumetinib in RAS-driven non-small cell lung cancerJianya Zhou, Shumeng Zhang, Xi Chen, et al.
Cancer Letters|July 29, 2017
The stem cell factor (SCF)/c-KIT system in carcinogenesis of reproductive tissues: What does the hormonal regulation tell us?Marília I Figueira, Henrique J Cardoso, Sara Correia, et al.
Pageof 1,706

Showing results (241-250 of 17,056) with videos related to

Sort By:
Pageof 1,706
Cancer Letters|August 12, 2017
PD-1/PD-L1 blockade enhances the efficacy of SA-GM-CSF surface-modified tumor vaccine in prostate cancerXiaojun Shi, Xinji Zhang, Jinlong Li, et al.
Cancer Letters|August 12, 2017
The HSP90 inhibitor, NVP-AUY922, attenuates intrinsic PI3K inhibitor resistance in KRAS-mutant non-small cell lung cancerKang-Seo Park, Hannah Yang, Junyoung Choi, et al.
Cancer Letters|August 5, 2017
Drug combination approach to overcome resistance to EGFR tyrosine kinase inhibitors in lung cancerChristy W S Tong, William K K Wu, Herbert H F Loong, et al.
Cancer Letters|August 6, 2017
EGFR/c-myc axis regulates TGFβ/Hippo/Notch pathway via epigenetic silencing miR-524 in gliomasKai Zhao, Qixue Wang, Yunfei Wang, et al.
Cancer Letters|September 27, 2017
Speeding towards individualized treatment for pancreatic cancer by taking an alternative roadJuan Iovanna, Nelson Dusetti
Cancer Letters|September 20, 2017
Up-regulation of Rho-associated kinase 1/2 by glucocorticoids promotes migration, invasion and metastasis of melanomaGao-Xiang Huang, Yan Wang, Jie Su, et al.
Cancer Letters|September 28, 2017
NEMO peptide inhibits the growth of pancreatic ductal adenocarcinoma by blocking NF-κB activationZhuonan Zhuang, Hao Li, Harold Lee, et al.
Cancer Letters|September 28, 2017
Targeting COPZ1 non-oncogene addiction counteracts the viability of thyroid tumor cellsMaria Chiara Anania, Elena Cetti, Daniele Lecis, et al.
Cancer Letters|September 4, 2017
Palbociclib, a selective CDK4/6 inhibitor, enhances the effect of selumetinib in RAS-driven non-small cell lung cancerJianya Zhou, Shumeng Zhang, Xi Chen, et al.
Cancer Letters|July 29, 2017
The stem cell factor (SCF)/c-KIT system in carcinogenesis of reproductive tissues: What does the hormonal regulation tell us?Marília I Figueira, Henrique J Cardoso, Sara Correia, et al.
Pageof 1,706